Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean f vito marino[Author] (12 results)?
Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, Zito Marino F, Ferraraccio F, Franco R. Panarese I, et al. Among authors: zito marino f. Expert Rev Anticancer Ther. 2017 May;17(5):417-425. doi: 10.1080/14737140.2017.1301207. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28277834 Review.
Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population.
Petrillo A, Tirino G, Zito Marino F, Pompella L, Sabetta R, Panarese I, Pappalardo A, Caterino M, Ventriglia A, Laterza MM, Morgillo F, Orditura M, Ciardiello F, Franco R, De Vita F. Petrillo A, et al. Among authors: zito marino f. Onco Targets Ther. 2020 Jan 29;13:867-876. doi: 10.2147/OTT.S229813. eCollection 2020. Onco Targets Ther. 2020. PMID: 32099391 Free PMC article.
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.
Cardone C, Blauensteiner B, Moreno-Viedma V, Martini G, Simeon V, Vitiello PP, Ciardiello D, Belli V, Matrone N, Troiani T, Morgillo F, Zito Marino F, Dentice M, Nappi A, Boccaccino A, Antoniotti C, Cremolini C, Pietrantonio F, Prager GW, Normanno N, Maiello E, Argiles G, Elez E, Signoriello G, Franco R, Falcone A, Tabernero J, Sibilia M, Ciardiello F, Martinelli E. Cardone C, et al. Among authors: zito marino f. Eur J Cancer. 2020 Oct;138:1-10. doi: 10.1016/j.ejca.2020.07.010. Epub 2020 Aug 17. Eur J Cancer. 2020. PMID: 32818762
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival.
Zito Marino F, Baselice S, Erra S, Ronchi A, Montella M, Morgillo F, Vicidomini G, Santini M, Poziello G, Cozzolino I, Accardo M, Franco R. Zito Marino F, et al. Appl Immunohistochem Mol Morphol. 2021 Mar 1;29(3):231-238. doi: 10.1097/PAI.0000000000000869. Appl Immunohistochem Mol Morphol. 2021. PMID: 32842027
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.
Del Gobbo A, Pellegrinelli A, Gaudioso G, Castellani M, Zito Marino F, Franco R, Palleschi A, Nosotti M, Bosari S, Vaira V, Ferrero S. Del Gobbo A, et al. Among authors: zito marino f. Histopathology. 2016 Apr;68(5):746-51. doi: 10.1111/his.12808. Epub 2015 Oct 23. Histopathology. 2016. PMID: 26272457
AIMS: The role of tumour metabolic and proliferative indices in predicting non-small-cell lung cancer (NSCLC) patients' prognosis is unclear. We correlated fluorine 18 ((18) F)-fluorodeoxyglucose (FDG)-positron emission tomography (PET) value and Ki67 index to patients' su …
AIMS: The role of tumour metabolic and proliferative indices in predicting non-small-cell lung cancer (NSCLC) patients' prognosis is unclear …